Mark Williams Shoulder Surgery: Phoenix Suns Paid $38 Million for Health, Not Talent

Last Thursday, Mark Williams lay down on an operating table in Phoenix to have the labrum in his left shoulder repaired. Shams Charania of ESPN confirmed the surgery the same day, in a single line stating that the center would be out long term. Less than an hour later, John Gambadoro of Arizona Sports 98.7 added a specific figure: roughly five months, meaning Williams can only return around the All-Star break.

In my newsroom in Penang, the first thing the team did was reopen the contract sheet. Three years, $38 million. For a center brought in to start, the right question is not how many points per game Phoenix loses, but how many starting appearances they lose, across how many games, and in exactly which stretch of the season.

A medical file more expensive than a skill file

An average annual value of $12.67 million places Williams in the mid-tier starting center bracket, far below the supermax threshold and also not the kind of deal that poisons a salary cap. Most of the reaction online will run along the lines of "the Suns burned money again," but $38 million does not burn Phoenix. It points to something else: the front office paid an accurate market price for a player whose medical file never allowed them peace of mind.

In his first three seasons in Charlotte, Williams never crossed the 44-game mark in a single season. Foot, ankle, thumb, back. Four different injury groups on one body not yet past the age of 25. Last season in a Phoenix jersey, he played 60 games at 11.7 points and 8.0 rebounds a night — the output of a healthy starting center, and nothing more.

There is one detail in the source material I want to flag for cross-checking: the description suggests Williams moved from Charlotte to Phoenix between seasons, but does not state when the move occurred. With any piece touching the salary cap, I require verification against primary sources before drawing conclusions about financial consequences. "Three sources are never redundant when one number decides someone else's career."

What the Phoenix paint will look like

The replacement plan fits neatly into two names: Khaman Maluach and Oso Ighodaro. Both are young, both are cheap, and neither has ever carried a primary center role at NBA level across an extended run of games.

Maluach made his mark at Summer League with 19.5 points and 12.8 rebounds, but that was four games against non-NBA opposition. Based on my experience tracking games in the preseason phase, I always file Summer League numbers in a separate drawer: the sample is too small, the opposition quality is too low, and the pace of play bears no resemblance to the real season. Using it to project NBA production is an inference with no statistical basis.

Ighodaro runs the opposite way. 6.5 points, 5.1 rebounds — unimpressive on paper. But he played all 82 games. On a team that just lost its starting center to injury, availability becomes the most expensive commodity on the market.

Phoenix's structural position is now clear: they have no proven backup center. They have two development slots. When a team loses its interior anchor, it usually picks one of two paths. The first is to elevate a raw big in order to preserve the drop-coverage defensive structure. The second is to shift to a smaller lineup, trading rim protection for mobility and switchability. Phoenix chose the first path, and chose it by splitting minutes between two players rather than betting everything on one.

That is a reasonable risk decision, but it carries a cost. Interior defense becomes diffuse, switching exposure rises, and errors accumulate game by game. In the Western Conference, where every week brings at least two centers who know how to attack the rim, those errors do not sit still.

I have written before that the five-substitution rule deepens a roster but also turns the final twenty minutes into a war of attrition. The Phoenix case is the reverse face of the same principle, with one difference: they lost their man before the game even began.

The blind spot sits in the medical room, not on the court

Media coverage focuses on the recovery timeline. What fewer people look at is who approved that $38 million, at what moment, and on the basis of what medical data.

A center who cannot clear 44 games in three consecutive seasons and is then signed to a three-year deal is not an accident. It is a deliberate decision, and the team's medical department is the body that has to sign off on it. If Williams' file was assessed correctly, Phoenix knew the high probability of absence in advance and accepted it as a cost. If not, the problem lies in the process, not in the player.

I have stood on the wrong side of a similar story before. "I was once faster than a phone call and paid for it with five million euros of credibility." That time I published the release clause of a Croatian midfielder at 65 million euros, when the correct figure was 60. I was one call short. Since then, every piece I write on injuries and contracts begins with a single test: in what other way could this number be read?

The same applies here. Gambadoro's five-month estimate is the opinion of a well-sourced local reporter, not an official statement from the club. The distance between those two categories of information determines how a team operates.

If the absence is confirmed as season-ending, Phoenix can apply for a Disabled Player Exception — a mechanism permitting the signing of a replacement player on a capped salary. If it is only five months, that right does not exist. Two legal scenarios, separated by exactly one word in an official notice.

What stands out is that Williams' contract remains fully guaranteed. He collects the full $38 million while unavailable. Dead money does not disappear; it merely moves from the production column to the foregone-opportunity column. "The summer market does not begin at the airport, but in the filing cabinet of the legal office." For Phoenix, that cabinet is open at precisely the moment the season starts.

Three scenarios for the rest of the season

The scenario I assign the highest probability: Phoenix rotates internally, Maluach receives 24 to 28 minutes a night, Ighodaro absorbs the remainder, and the team accepts a drop of a few places in the play-in race. No major trade is made, and the season is redefined as a development year.

The second scenario: the team slides quickly across the first twenty games, and the front office is forced into the veteran center market — short deals, low cost, no major asset sacrifice. This is the cheapest path and also the least effective, because a veteran center signed mid-season rarely has the stamina to play 25 minutes a night in the West.

The third scenario, rarely mentioned: Maluach plays better than expected, and when Williams returns in February, Phoenix faces a starting-job contest between the man just paid $38 million and the man currently playing better. This is the kind of situation every locker room knows how to handle on paper, but rarely handles cleanly in reality.

Among these three, I place my trust in the first. Not because it is attractive, but because it is the only scenario that does not force Phoenix to trade assets in a season where they still lack enough data to know where they stand.

The variable nobody wants to mention

For any center returning from labrum surgery, re-injury risk is the most under-priced variable. The labrum bears load on every rebound contest and every shot-blocking reach. Williams will have to repeat that motion dozens of times a night, in a season where Phoenix needs him on the floor rather than watching.

And if he re-injures it, the story pivots. From "bad luck" to "failed medical assessment." "There is no such thing as junk rumors, only people who read rumors carelessly." How long Williams is out is only the visible part. The submerged part is how Phoenix handles that stretch — patience with the internal option, or panic in the market. The identity of this season rests on that choice, and they have roughly twenty games to make it.